Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.dsx.2021.02.010 http://scihub22266oqcxt.onion/10.1016/j.dsx.2021.02.010 33588200!7871808!33588200     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33588200&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Diabetes+Metab+Syndr 2021 ; 15 (1): 433-437 Nephropedia Template TP {{tp|p=33588200|t=2021. Adapting to telemedicine in the COVID-19 era: Feasibility of dried blood spot testing for hemoglobin A1c |pdf=|usr=}}{{33588200}} gab.com Text Adapting to telemedicine in the COVID-19 era: Feasibility of dried blood spot testing for hemoglobin A1c JO: Diabetes Metab Syndr http://www.kidney.de/pget.php?&tw=1&pmid=33588200 #FOAvip BACKGROUND AND AIMS: The COVID-19 pandemic has led to a rapid growth in the use of telemedicine for delivery of ambulatory diabetes care. This study evaluated the feasibility of remote HbA1c monitoring via dried blood spot (DBS) testing to support assessment of glycemic control for telemedicine visits and examined clinical and demographic characteristics associated with patient completion of DBS testing. METHODS: Providers could place orders for DBS HbA1c 3 weeks prior to telemedicine visits. Feasibility was assessed by examining DBS completion rates, time to completion, and availability of DBS results prior to telemedicine visits. Chi-square tests and Mann Whitney tests were used to assess whether completion rates were associated with participant characteristics. RESULTS: Of 303 DBS orders placed for telemedicine visits in June 2020, 162 patients completed the DBS test for a completion rate of (53.4%). Average time from collection at home to result being reported was 6.9 (3.8) days. The DBS result was available in 67.6% of patients who completed successful DBS, before the telemedicine clinic visit. HbA1c was lower in the DBS completion group as compared to the non-completion group (8.2% vs. 8.9%, p = 0.01). No other clinical or demographic characteristics were significantly different between the two groups. CONCLUSION: Remote HbA1c monitoring via DBS is feasible and offers an avenue to support assessment of glycemic control for patients seen via telemedicine. Future work should focus on improving clinic and laboratory processes to support remote DBS collection. Twit Text FOAVip Adapting to telemedicine in the COVID-19 era: Feasibility of dried blood spot testing for hemoglobin A1c ????Diabetes Metab Syndr http://www.kidney.de/pget.php?&tw=1&pmid=33588200 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33588200 #FOAvip English Wikipedia <ref>{{Cite pmid|33588200}}</ref> Adapting to telemedicine in the COVID-19 era: Feasibility of dried blood spot testing for hemoglobin A1c #MMPMID33588200 Roberts AJ; Malik F; Pihoker C; Dickerson JA Diabetes Metab Syndr 2021[Jan]; 15 (1): 433-437 PMID33588200show ga BACKGROUND AND AIMS: The COVID-19 pandemic has led to a rapid growth in the use of telemedicine for delivery of ambulatory diabetes care. This study evaluated the feasibility of remote HbA1c monitoring via dried blood spot (DBS) testing to support assessment of glycemic control for telemedicine visits and examined clinical and demographic characteristics associated with patient completion of DBS testing. METHODS: Providers could place orders for DBS HbA1c 3 weeks prior to telemedicine visits. Feasibility was assessed by examining DBS completion rates, time to completion, and availability of DBS results prior to telemedicine visits. Chi-square tests and Mann Whitney tests were used to assess whether completion rates were associated with participant characteristics. RESULTS: Of 303 DBS orders placed for telemedicine visits in June 2020, 162 patients completed the DBS test for a completion rate of (53.4%). Average time from collection at home to result being reported was 6.9 (3.8) days. The DBS result was available in 67.6% of patients who completed successful DBS, before the telemedicine clinic visit. HbA1c was lower in the DBS completion group as compared to the non-completion group (8.2% vs. 8.9%, p = 0.01). No other clinical or demographic characteristics were significantly different between the two groups. CONCLUSION: Remote HbA1c monitoring via DBS is feasible and offers an avenue to support assessment of glycemic control for patients seen via telemedicine. Future work should focus on improving clinic and laboratory processes to support remote DBS collection. |Adaptation, Psychological[MESH] |Adolescent[MESH] |COVID-19/*epidemiology/prevention & control[MESH] |Child[MESH] |Diabetes Mellitus/*blood/diagnosis/*epidemiology[MESH] |Dried Blood Spot Testing/*methods/trends[MESH] |Feasibility Studies[MESH] |Female[MESH] |Glycated Hemoglobin/*metabolism[MESH] |Humans[MESH] |Male[MESH]Adapting to telemedicine in the COVID-19 era: Feasibility of dried blo(epmc).pdf DeepDyve Pubget Overpricing